These studies provide the basis for a critical assessment of the views of the general public and physicians on genetics and genetic testing services in several European countries, while these surveys could be readily replicated in other countries in Europe with the ultimate aim of improving the public understanding of genetics and genetic testing, and facilitating the incorporation of genomic medicine
into everyday clinical practice.
Fortunately, conducting randomized trials over the decades, intervention researchers have produced numerous manual - guided, evidence - based treatments (EBTs) for depression, anxiety, and conduct in youth.2 Unfortunately, these treatments have not been incorporated
into most
everyday clinical practice.3 - 5 A common view is that the complexity and comorbidity of many clinically referred youths, whose problems and treatment needs can shift during treatment, may pose problems for EBT protocols, which are typically designed for single or homogeneous clusters of disorders, developed and tested with recruited youths who differ from patients seen in
everyday clinical practice, and involve a predetermined sequence of prescribed session contents, limiting their flexibility.3 - 8 Indeed, trials testing these protocols against usual care for young patients in
clinical practice have produced mixed findings, with EBTs often failing to outperform usual care.7, 9